1 2475 94 YOGA AS AN ADJUNCT FOR MANAGEMENT OF OPIOID DEPENDENCE SYNDROME: A NINE-MONTH FOLLOW-UP CASE REPORT. OPIOID DEPENDENCE SYNDROME (ODS) IS A CHRONIC RELAPSING REMITTING CONDITION ASSOCIATED WITH SIGNIFICANT IMPAIRMENT AND MORTALITY RISK. OPIOID SUBSTITUTION THERAPY IS USED WORLDWIDE, BUT LONG-TERM RETENTION RATES ARE LOW AND THERE IS RISK OF MISUSE AND DIVERSION. YOGA PRACTICE CAN IMPROVE QUALITY OF LIFE, REDUCE CHRONIC PAIN, AND ENHANCE ENDOGENOUS OPIOIDS (BETA-ENDORPHINS). WE DESCRIBE A CASE OF ODS WHERE YOGA WAS ADDED TO THE CONVENTIONAL MANAGEMENT AND WHO WAS FOLLOWED UP FOR 9 MONTHS. ASSESSMENTS WERE DONE FOR CLINICAL SYMPTOMS, URINE DRUG SCREENING, PLASMA BETA-ENDORPHINS, AND BUPRENORPHINE DOSAGE. WE OBSERVED AN IMPROVEMENT IN HIS CLINICAL SYMPTOMS AND REDUCTION IN THE REQUIREMENTS FOR BUPRENORPHINE. A SLIGHT INCREASE IN BASAL PLASMA BETA-ENDORPHIN LEVELS WAS ALSO OBSERVED AT THE 9-MONTH FOLLOW-UP (FROM 2.02 PMOL/L AT BASELINE TO 6.51 PMOL/L). 2021 2 985 25 EFFECTS OF HATHA YOGA AND OMKAR MEDITATION ON CARDIORESPIRATORY PERFORMANCE, PSYCHOLOGIC PROFILE, AND MELATONIN SECRETION. OBJECTIVES: TO EVALUATE EFFECTS OF HATHA YOGA AND OMKAR MEDITATION ON CARDIORESPIRATORY PERFORMANCE, PSYCHOLOGIC PROFILE, AND MELATONIN SECRETION. SUBJECTS AND METHODS: THIRTY HEALTHY MEN IN THE AGE GROUP OF 25-35 YEARS VOLUNTEERED FOR THE STUDY. THEY WERE RANDOMLY DIVIDED IN TWO GROUPS OF 15 EACH. GROUP 1 SUBJECTS SERVED AS CONTROLS AND PERFORMED BODY FLEXIBILITY EXERCISES FOR 40 MINUTES AND SLOW RUNNING FOR 20 MINUTES DURING MORNING HOURS AND PLAYED GAMES FOR 60 MINUTES DURING EVENING HOURS DAILY FOR 3 MONTHS. GROUP 2 SUBJECTS PRACTICED SELECTED YOGIC ASANAS (POSTURES) FOR 45 MINUTES AND PRANAYAMA FOR 15 MINUTES DURING THE MORNING, WHEREAS DURING THE EVENING HOURS THESE SUBJECTS PERFORMED PREPARATORY YOGIC POSTURES FOR 15 MINUTES, PRANAYAMA FOR 15 MINUTES, AND MEDITATION FOR 30 MINUTES DAILY, FOR 3 MONTHS. ORTHOSTATIC TOLERANCE, HEART RATE, BLOOD PRESSURE, RESPIRATORY RATE, DYNAMIC LUNG FUNCTION (SUCH AS FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME IN 1 SECOND, FORCED EXPIRATORY VOLUME PERCENTAGE, PEAK EXPIRATORY FLOW RATE, AND MAXIMUM VOLUNTARY VENTILATION), AND PSYCHOLOGIC PROFILE WERE MEASURED BEFORE AND AFTER 3 MONTHS OF YOGIC PRACTICES. SERIAL BLOOD SAMPLES WERE DRAWN AT VARIOUS TIME INTERVALS TO STUDY EFFECTS OF THESE YOGIC PRACTICES AND OMKAR MEDITATION ON MELATONIN LEVELS. RESULTS: YOGIC PRACTICES FOR 3 MONTHS RESULTED IN AN IMPROVEMENT IN CARDIORESPIRATORY PERFORMANCE AND PSYCHOLOGIC PROFILE. THE PLASMA MELATONIN ALSO SHOWED AN INCREASE AFTER THREE MONTHS OF YOGIC PRACTICES. THE SYSTOLIC BLOOD PRESSURE, DIASTOLIC BLOOD PRESSURE, MEAN ARTERIAL PRESSURE, AND ORTHOSTATIC TOLERANCE DID NOT SHOW ANY SIGNIFICANT CORRELATION WITH PLASMA MELATONIN. HOWEVER, THE MAXIMUM NIGHT TIME MELATONIN LEVELS IN YOGA GROUP SHOWED A SIGNIFICANT CORRELATION (R = 0.71, P < 0.05) WITH WELL-BEING SCORE. CONCLUSION: THESE OBSERVATIONS SUGGEST THAT YOGIC PRACTICES CAN BE USED AS PSYCHOPHYSIOLOGIC STIMULI TO INCREASE ENDOGENOUS SECRETION OF MELATONIN, WHICH, IN TURN, MIGHT BE RESPONSIBLE FOR IMPROVED SENSE OF WELL-BEING. 2004 3 737 25 EFFECT OF PRANAYAMA & YOGA-ASANA ON COGNITIVE BRAIN FUNCTIONS IN TYPE 2 DIABETES-P3 EVENT RELATED EVOKED POTENTIAL (ERP). BACKGROUND & OBJECTIVES: ELECTROPHYSIOLOGICAL EVIDENCE OF DELAYED COGNITION AS MEASURED BY P300, AN EVOKED POTENTIAL IS OBSERVED IN DIABETES MELLITUS. P300 (OR P3) IS A COMPONENT OF ENDOGENOUS CEREBRAL EVOKED RESPONSE THAT ASSESSES HIGHER FUNCTIONS OF THE BRAIN. OUR STUDY AIMS TO SEE THE ROLE OF PRANAYAMA AND YOGA-ASANA ON P300 LATENCY AND AMPLITUDE IN TYPE 2 DIABETIC PATIENTS. METHODS: SIXTY PATIENTS OF TYPE 2 DIABETES WERE RECRUITED FROM DIABETIC CLINIC AND DIVIDED INTO TWO GROUPS - CONTROL GROUP ON ONLY CONVENTIONAL MEDICAL THERAPY AND YOGA-GROUP ON CONVENTIONAL MEDICAL THERAPY ALONG WITH PRANAYAMA AND YOGA-ASANA. BASAL RECORDINGS OF P300 AND BLOOD GLUCOSE WERE TAKEN AT THE TIME OF RECRUITMENT AND SECOND RECORDINGS REPEATED AFTER FORTY FIVE DAYS FOR BOTH THE GROUPS. P300 WAS RECORDED ON NIHON KOHDEN NEUROPACK MU MEB 9100 USING AUDITORY "ODD-BALL PARADIGM". THE DATA WERE ANALYSED USING REPEATED MEASURES ANALYSIS OF VARIANCE (ANOVA) FOLLOWED BY TUKEY'S TEST AT 5 PER CENT LEVEL OF SIGNIFICANCE. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENT IN THE LATENCY AND THE AMPLITUDE OF N200, P300 WAS OBSERVED IN THE YOGA GROUP AS COMPARED TO THE CONTROL GROUP. INTERPRETATION & CONCLUSION: OUR DATA SUGGEST THAT YOGA HAS A BENEFICIAL EFFECT ON P300 AND THUS CAN BE INCORPORATED ALONG WITH THE CONVENTIONAL MEDICAL THERAPY FOR IMPROVING COGNITIVE BRAIN FUNCTIONS IN DIABETES. 2010 4 875 24 EFFECT OF YOGA THERAPY ON PLASMA OXYTOCIN AND FACIAL EMOTION RECOGNITION DEFICITS IN PATIENTS OF SCHIZOPHRENIA. CONTEXT: YOGA THERAPY HAS BEEN DEMONSTRATED TO BE USEFUL IN TREATMENT OF NEGATIVE SYMPTOMS AND IMPROVING THE SOCIO-OCCUPATIONAL FUNCTIONING AND EMOTION RECOGNITION DEFICITS IN ANTIPSYCHOTIC-STABILIZED SCHIZOPHRENIA PATIENTS. OXYTOCIN HAS BEEN RECENTLY IMPLICATED IN SOCIAL COGNITION DEFICITS IN SCHIZOPHRENIA. THE EFFECT OF YOGA THERAPY ON OXYTOCIN LEVELS IN SCHIZOPHRENIA HAS NOT BEEN STUDIED. AIMS: THIS STUDY AIMED TO ASSESS THE EFFECT OF YOGA THERAPY ON SYMPTOMS, SOCIO-OCCUPATIONAL FUNCTIONING, FACIAL EMOTION RECOGNITION DEFICITS AND PLASMA OXYTOCIN LEVELS IN ANTIPSYCHOTIC STABILIZED SCHIZOPHRENIA PATIENTS. SETTINGS AND DESIGN: RANDOMIZED CONTROLLED STUDY ON 43 CONSENTING, MEDICATION STABILIZED PATIENTS WITH SCHIZOPHRENIA IN A TERTIARY PSYCHIATRIC CENTER USING YOGA INTERVENTION AND WAITLISTED GROUPS. MATERIALS AND METHODS: A TOTAL OF 43 SCHIZOPHRENIA PATIENTS WERE RANDOMIZED TO YOGA GROUP (N=15) OR WAITLIST GROUP (N=28). PATIENTS IN THE YOGA GROUP RECEIVED TRAINING IN A SPECIFIC YOGA THERAPY MODULE FOR SCHIZOPHRENIA. PATIENTS IN BOTH GROUPS WERE CONTINUED ON STABLE ANTIPSYCHOTIC MEDICATION. ASSESSMENTS INCLUDED SCALE FOR ASSESSMENT OF POSITIVE SYMPTOMS, SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOMS, SOCIO-OCCUPATIONAL FUNCTIONING SCALE AND TOOL FOR RECOGNITION OF EMOTIONS IN NEUROPSYCHIATRIC DISORDERS (TRENDS) AND PLASMA OXYTOCIN LEVELS; PERFORMED AT BASELINE AND AT THE END OF 1 MONTH. RESULTS: A TOTAL OF 15 PATIENTS IN THE YOGA GROUP AND 12 IN WAITLIST GROUP COMPLETED THE STUDY. THE YOGA THERAPY GROUP SHOWED A SIGNIFICANT IMPROVEMENT IN SOCIO-OCCUPATIONAL FUNCTIONING, PERFORMANCE ON TRENDS (P<0.001) AND PLASMA INCREASE IN OXYTOCIN LEVELS (P=0.01) AS COMPARED WITH THE WAITLIST GROUP. CONCLUSION: THE STUDY SUPPORTED THE ROLE OF ADD-ON YOGA THERAPY IN MANAGEMENT OF SCHIZOPHRENIA AND DEMONSTRATED AN IMPROVEMENT IN ENDOGENOUS PLASMA OXYTOCIN LEVELS IN SCHIZOPHRENIA PATIENTS RECEIVING YOGA THERAPY. 2013 5 2254 28 THE ORIGIN AND CLINICAL RELEVANCE OF YOGA NIDRA. YOGA NIDRA, ALSO KNOWN AS 'YOGIC SLEEP', IS A SIMPLIFIED FORM OF AN ANCIENT TANTRIC RELAXATION TECHNIQUE. THE MOST GENERAL DESCRIPTION OF THE PRACTICE IS THAT IT COMBINES GUIDED MENTAL IMAGERY WITH A SPECIFIC YOGA POSTURE CALLED SHAVASANA (OR "CORPSE POSE"). THE GOAL OF YOGA NIDRA IS TO PROMOTE A PROFOUND STATE OF RELAXATION, WHICH DIFFERS FROM SLEEP INASMUCH AS THERE IS STILL AN AWARENESS OF ONE'S SURROUNDINGS. WHILE SEVERAL COMPONENTS OF THE PRACTICE HAVE BEEN KNOWN SINCE ANCIENT TIMES, IT WAS NOT UNTIL THE 1960S THAT AN UPDATED AND SYSTEMATIZED SYSTEM OF PRACTICE WAS INTRODUCED TO THE PUBLIC THROUGH THE WRITINGS OF SWAMI SATYANANDA SARASWATI. UNLIKE OTHER SCHOOLS OF YOGA, WHICH EMPHASIZE CONCENTRATION OR CONTEMPLATION, YOGA NIDRA'S GOAL IS COMPLETE RELAXATION. AS SUCH, ITS ADVOCATES CLAIM THAT IT IS SUITABLE FOR ALL INDIVIDUALS, FROM BEGINNERS TO ADVANCED PRACTITIONERS OF YOGA. THE CALM INNER STILLNESS INDUCED BY YOGA NIDRA IS CLAIMED BY PRACTITIONERS TO BE AN EFFECTIVE STRESS MANAGEMENT TOOL AS WELL AS A MEANS FOR ATTAINING GREATER RECEPTIVITY TO PERSONAL RESOLUTIONS. THESE RESOLUTIONS CAN RANGE FROM THE GOAL OF ACHIEVING SELF-TRANSFORMATION, ENHANCING CREATIVITY, OR IMPROVING ONE'S LEARNING ABILITY. ADDITIONALLY, YOGA NIDRA IS CLAIMED TO PROMOTE BENEFICIAL CHANGES IN PHYSIOLOGICAL AND MENTAL HEALTH. THE FOLLOWING NARRATIVE REVIEW SUMMARIZES THE BASIC STEPS USED TO ACHIEVE THE FINAL STATE OF YOGA NIDRA RELAXATION AS WELL AS SOME RECENT EXPERIMENTAL FINDINGS REGARDING ITS PHYSIOLOGICAL AND PSYCHOLOGICAL EFFECTS. STANDARD RESEARCH DATABASES WERE SEARCHED FOR RELEVANT ARTICLES. CLINICAL STUDIES HAVE SHOWN THAT YOGA NIDRA MEDITATION IS ASSOCIATED WITH POSITIVE PHYSIOLOGICAL CHANGES, INCLUDING IMPROVEMENTS IN SEVERAL HEMATOLOGICAL VARIABLES, RED BLOOD CELL COUNTS, BLOOD GLUCOSE LEVELS, AND HORMONAL STATUS. TWO NEUROIMAGING STUDIES HAVE SHOWN THAT YOGA NIDRA PRODUCES CHANGES IN ENDOGENOUS DOPAMINE RELEASE AND CEREBRAL BLOOD FLOW, A FURTHER CONFIRMATION THAT ITS EFFECTS ON THE CNS ARE OBJECTIVELY MEASURABLE. THE PRACTICE HAS ALSO BEEN SHOWN TO REDUCE PSYCHOMETRICALLY MEASURED INDICES OF MILD DEPRESSION AND ANXIETY, ALTHOUGH THESE BENEFITS WERE NOT SHOWN IN AN EXPERIMENTAL STUDY TO EXTEND TO SEVERE DEPRESSION OR SEVERE ANXIETY. 2022 6 872 27 EFFECT OF YOGA THERAPY ON FACIAL EMOTION RECOGNITION DEFICITS, SYMPTOMS AND FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA. OBJECTIVE: FACIAL EMOTION RECOGNITION DEFICITS HAVE BEEN CONSISTENTLY DEMONSTRATED IN SCHIZOPHRENIA AND CAN IMPAIR SOCIO-OCCUPATIONAL FUNCTIONING IN THESE PATIENTS. TREATMENTS TO IMPROVE THESE DEFICITS IN ANTIPSYCHOTIC-STABILIZED PATIENTS HAVE NOT BEEN WELL STUDIED. YOGA THERAPY HAS BEEN DESCRIBED TO IMPROVE FUNCTIONING IN VARIOUS DOMAINS IN SCHIZOPHRENIA; HOWEVER, ITS EFFECT ON FERD IS NOT KNOWN. METHOD: ANTIPSYCHOTIC-STABILIZED PATIENTS RANDOMIZED TO RECEIVE YOGA (N=27), EXERCISE (N=17) OR WAITLIST GROUP (N=22) WERE ASSESSED AT BASELINE, 2ND MONTH, AND 4TH MONTH OF FOLLOW-UP BY RATERS BLIND TO GROUP STATUS. ASSESSMENTS INCLUDED POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS), SOCIO-OCCUPATIONAL FUNCTIONING SCALE (SOFS), AND TOOL FOR RECOGNITION OF EMOTIONS IN NEUROPSYCHIATRIC DISORDERS (TRENDS). RESULTS: THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN BASELINE FERD AND SOCIO-OCCUPATIONAL FUNCTIONING (R=0.3, P=0.01). PAIRED SAMPLES T TEST SHOWED SIGNIFICANT IMPROVEMENT IN POSITIVE AND NEGATIVE SYMPTOMS, SOCIO-OCCUPATIONAL FUNCTIONING AND PERFORMANCE ON TRENDS (P<0.05) IN THE YOGA GROUP, BUT NOT IN THE OTHER TWO GROUPS. MAXIMUM IMPROVEMENT OCCURRED AT THE END OF 2 MONTHS, AND IMPROVEMENT IN POSITIVE AND NEGATIVE SYMPTOMS PERSISTED AT THE END OF 4 MONTHS. CONCLUSION: YOGA THERAPY CAN BE A USEFUL ADD-ON TREATMENT TO IMPROVE PSYCHOPATHOLOGY, FERD, AND SOCIO-OCCUPATIONAL FUNCTIONING IN ANTIPSYCHOTIC-STABILIZED PATIENTS WITH SCHIZOPHRENIA. 2011 7 2771 17 YOGA REDUCES SYMPTOMS OF DISTRESS IN TSUNAMI SURVIVORS IN THE ANDAMAN ISLANDS. A MONTH AFTER THE DECEMBER 2004 TSUNAMI THE EFFECT OF A 1 WEEK YOGA PROGRAM WAS EVALUATED ON SELF RATED FEAR, ANXIETY, SADNESS AND DISTURBED SLEEP IN 47 SURVIVORS IN THE ANDAMAN ISLANDS. POLYGRAPH RECORDINGS OF THE HEART RATE, BREATH RATE AND SKIN RESISTANCE WERE ALSO MADE. AMONG THE 47 PEOPLE, 31 WERE SETTLERS FROM THE MAINLAND (I.E. INDIA, ML GROUP) AND 16 WERE ENDOGENOUS PEOPLE (EP GROUP). THERE WAS A SIGNIFICANT DECREASE IN SELF RATED FEAR, ANXIETY, SADNESS AND DISTURBED SLEEP IN BOTH GROUPS, AND IN THE HEART AND BREATH RATE IN THE ML GROUP, AND IN THE BREATH RATE ALONE IN THE EP GROUP, FOLLOWING YOGA (P < 0.05, T-TEST). THIS SUGGESTS THAT YOGA PRACTICE MAY BE USEFUL IN THE MANAGEMENT OF STRESS FOLLOWING A NATURAL DISASTER IN PEOPLE WITH WIDELY DIFFERING SOCIAL, CULTURAL AND SPIRITUAL BELIEFS. 2007 8 1836 13 PSYCHOPHYSIOLOGICAL CORRELATES OF THE PRACTICE OF TANTRIC YOGA MEDITATION. AUTONOMIC AND ELECTROENCEPHALOGRAPHIC (EEG) CORRELATES OF TANTRIC YOGA MEDITATION WERE STUDIED IN THREE GROUPS OF SUBJECTS AS THEY PROGRESSED FROM NORMAL CONSCIOUSNESS INTO MEDITATION. GROUPS DIFFERED IN THEIR LEVEL OF MEDITATION PROFICIENCY. MEASURES OF SKIN RESISTANCE, HEART RATE, RESPIRATION, AUTONOMIC ORIENTING RESPONSES, RESTING EEG, EEG ALPHA AND THETA FREQUENCIES, SLEEP-SCORED EEG, AVERAGED EVOKED RESPONSES, AND SUBJECTIVE EXPERIENCE WERE EMPLOYED. UNLIKE MOST PREVIOUSLY REPORTED MEDITATION STUDIES, PROFICIENT MEDITATORS DEMONSTRATED INCREASED AUTONOMIC ACTIVATION DURING MEDITATION WHILE UNEXPERIENCED MEDITATORS DEMONSTRATED AUTONOMIC RELAXATION. DURING MEDITATION, PROFICIENT MEDITATORS DEMONSTRATED INCREASED ALPHA AND THETA POWER, MINIMAL EVIDENCE OF EEG-DEFINED SLEEP, AND DECREASED AUTONOMIC ORIENTING TO EXTERNAL STIMULATION. AN EPISODE OF SUDDEN AUTONOMIC ACTIVATION WAS OBSERVED THAT WAS CHARACTERIZED BY THE MEDITATOR AS AN APPROACH TO THE YOGIC ECSTATIC STATE OF INTENSE CONCENTRATION. THESE FINDINGS CHALLENGE THE CURRENT "RELAXATION" MODEL OF MEDITATIVE STATES. 1978 9 747 19 EFFECT OF SAHAJA YOGA MEDITATION ON AUDITORY EVOKED POTENTIALS (AEP) AND VISUAL CONTRAST SENSITIVITY (VCS) IN EPILEPTICS. THE EFFECT OF SAHAJA YOGA MEDITATION ON 32 PATIENTS WITH PRIMARY IDIOPATHIC EPILEPSY ON REGULAR AND MAINTAINED ANTIEPILEPTIC MEDICATION WAS STUDIED. THE PATIENTS WERE RANDOMLY DIVIDED INTO 3 GROUPS: GROUP I PRACTICED SAHAJA YOGA MEDITATION TWICE DAILY FOR 6 MONTHS UNDER PROPER GUIDANCE; GROUP II PRACTICED POSTURAL EXERCISES MIMICKING THE MEDITATION FOR THE SAME DURATION; AND GROUP III WAS THE CONTROL GROUP. VISUAL CONTRAST SENSITIVITY (VCS), AUDITORY EVOKED POTENTIALS (AEP), BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEP), AND MID LATENCY RESPONSES (MLR) WERE RECORDED INITIALLY (0 MONTH) AND AT 3 AND 6 MONTHS FOR EACH GROUP. THERE WAS A SIGNIFICANT IMPROVEMENT IN VCS FOLLOWING MEDITATION PRACTICE IN GROUP I PARTICIPANTS. NA, THE FIRST PROMINENT NEGATIVE PEAK OF MLR AND PA, THE POSITIVE PEAK FOLLOWING NA DID NOT REGISTER CHANGES IN LATENCY. THE NA-PA AMPLITUDE OF MLR ALSO SHOWED A SIGNIFICANT INCREASE. THERE WERE NO SIGNIFICANT CHANGES IN THE ABSOLUTE AND INTERPEAK LATENCIES OF BAEP. THE REDUCED LEVEL OF STRESS FOLLOWING MEDITATION PRACTICE MAY MAKE PATIENTS MORE RESPONSIVE TO SPECIFIC STIMULI. SAHAJA YOGA MEDITATION APPEARS TO BRING ABOUT CHANGES IN SOME OF THE ELECTROPHYSIOLOGICAL RESPONSES STUDIED IN EPILEPTIC PATIENTS. 2000 10 213 18 A STUDY OF RESPONSE PATTERN OF NON-INSULIN DEPENDENT DIABETICS TO YOGA THERAPY. CHANGES IN BLOOD GLUCOSE AND GLUCOSE TOLERANCE BY ORAL GLUCOSE TOLERANCE TEST (OGTT) AFTER 40 DAYS OF YOGA THERAPY IN 149 NON-INSULIN-DEPENDENT DIABETICS (NIDDM) WERE INVESTIGATED. THE RESPONSE TO YOGA IN THESE SUBJECTS WAS CATEGORIZED ACCORDING TO A SEVERITY SCALE INDEX (SSI) BASED ON AREA INDEX TOTAL (AIT) UNDER OGTT CURVE. ONE HUNDRED AND FOUR PATIENTS SHOWED A FAIR TO GOOD RESPONSE TO THE YOGA THERAPY. THERE WAS A SIGNIFICANT REDUCTION IN HYPERGLYCEMIA AND AIT WITH DECREASE IN ORAL HYPOGLYCEMIA AND AIT WITH DECREASE IN ORAL HYPOGLYCEMIC DRUGS REQUIRED FOR MAINTENANCE OF NORMOGLYCEMIA. IT IS CONCLUDED THAT YOGA, A SIMPLE AND ECONOMICAL THERAPY, MAY BE CONSIDERED A BENEFICIAL ADJUVANT FOR NIDDM PATIENTS. 1993 11 2056 26 THE BENEFICIAL EFFECT OF YOGA IN DIABETES. TWENTY NIDDM SUBJECTS (MILD TO MODERATE DIABETICS) IN THE AGE GROUP OF 30-60 YEARS WERE SELECTED FROM THE OUT PATIENT CLINIC OF G.T.B. HOSPITAL. THEY WERE ON A 40 DAYS YOGA ASANA REGIME UNDER THE SUPERVISION OF A YOGA EXPERT. 13 SPECIFIC YOGA ASANAS < OR = DONE BY TYPE 2 DIABETES PATIENTS INCLUDED. SURYA NAMASKAR, TRIKONASANA, TADASANA, SUKHASANA, PADMASANA, BHASTRIKA PRANAYAMA, PASHIMOTTANASANA, ARDHMATSYENDRASANA, PAWANMUKTASANA, BHUJANGASANA, VAJRASANA, DHANURASANA AND SHAVASANA ARE BENEFICIAL FOR DIABETES MELLITUS. SERUM INSULIN, PLASMA FASTING AND ONE HOUR POSTPRANDIAL BLOOD GLUCOSE LEVELS AND ANTHROPOMETRIC PARAMETERS WERE MEASURED BEFORE AND AFTER YOGA ASANAS. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING GLUCOSE LEVELS FROM BASAL 208.3 +/- 20.0 TO 171.7 +/- 19.5 MG/DL AND ONE HOUR POSTPRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 295.3 +/- 22.0 TO 269.7 +/- 19.9 MG/DL. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATOENDOCRINE MECHANISM AFFECTING INSULIN KINETICS WAS WORKED OUT. A SIGNIFICANT DECREASE IN WAIST-HIP RATIO AND CHANGES IN INSULIN LEVELS WERE ALSO OBSERVED, SUGGESTING A POSITIVE EFFECT OF YOGA ASANAS ON GLUCOSE UTILISATION AND FAT REDISTRIBUTION IN NIDDM. YOGA ASANAS MAY BE USED AS AN ADJUNCT WITH DIET AND DRUGS IN THE MANAGEMENT OF TYPE 2 DIABETES. 2005 12 750 23 EFFECT OF SAHAJA YOGA PRACTICE ON STRESS MANAGEMENT IN PATIENTS OF EPILEPSY. AN ATTEMPT WAS MADE TO EVALUATE THE EFFECT OF SAHAJA YOGA MEDITATION IN STRESS MANAGEMENT IN PATIENTS OF EPILEPSY. THE STUDY WAS CARRIED OUT ON 32 PATIENTS OF EPILEPSY WHO WERE RENDOMLY DIVIDED INTO 3 GROUPS: GROUP I SUBJECTS PRACTISED SAHAJA YOGA MEDITATION FOR 6 MONTHS, GROUP II SUBJECTS PRACTISED POSTURAL EXERCISES MIMICKING SAHAJA YOGA AND GROUP III SERVED AS THE EPILEPTIC CONTROL GROUP. GALVANIC SKIN RESISTANCE (GSR), BLOOD LACTATE AND URINARY VINYL MANDELIC ACID (U-VMA) WERE RECORDED AT 0, 3 AND 6 MONTHS. THERE WERE SIGNIFICANT CHANGES AT 3 & 6 MONTHS AS COMPARED TO 0 MONTH VALUES IN GSR, BLOOD LACTATE AND U-VMA LEVELS IN GROUP I SUBJECTS, BUT NOT IN GROUP II AND GROUP III SUBJECTS. THE RESULTS INDICATE THAT REDUCTION IN STRESS FOLLOWING SAHAJA YOGA PRACTICE MAY BE RESPONSIBLE FOR CLINICAL IMPROVEMENT WHICH HAD BEEN EARLIER REPORTED IN PATIENTS WHO PRACTISED SAHAJA YOGA. 1995 13 2298 18 THERAPEUTIC ROLE OF YOGA IN TYPE 2 DIABETES. YOGA ORIGINATED IN INDIA MORE THAN 5,000 YEARS AGO AND IS A MEANS OF BALANCING AND HARMONIZING THE BODY, MIND, AND EMOTIONS. YOGA PRACTICE IS USEFUL IN THE MANAGEMENT OF VARIOUS LIFESTYLE DISEASES, INCLUDING TYPE 2 DIABETES. PSYCHO-NEURO-ENDOCRINE AND IMMUNE MECHANISMS ARE INVOLVED IN THE BENEFICIAL EFFECTS OF YOGA ON DIABETES. INCORPORATION OF YOGA PRACTICE IN DAILY LIFE HELPS TO ATTAIN GLYCAEMIC CONTROL AND REDUCES THE RISK OF COMPLICATIONS IN PEOPLE WITH DIABETES. IN THIS REVIEW, WE BRIEFLY DESCRIBE THE ROLE OF VARIOUS YOGA PRACTICES IN THE MANAGEMENT OF DIABETES BASED ON EVIDENCE FROM VARIOUS CLINICAL STUDIES. 2018 14 2886 22 YOGA: BALANCING THE EXCITATION-INHIBITION EQUILIBRIUM IN PSYCHIATRIC DISORDERS. SOCIAL BEHAVIORAL DISTURBANCES ARE CENTRAL TO MOST PSYCHIATRIC DISORDERS. A DISEQUILIBRIUM WITHIN THE CORTICAL EXCITATORY AND INHIBITORY NEUROTRANSMITTER SYSTEMS UNDERLIES THESE DEFICITS. GAMMA-AMINOBUTYRIC ACID (GABA) AND GLUTAMATE ARE THE MOST ABUNDANT EXCITATORY AND INHIBITORY NEUROTRANSMITTERS IN THE BRAIN THAT CONTRIBUTE TO THIS EQUILIBRIUM. SEVERAL CONTEMPORARY THERAPIES USED IN TREATING PSYCHIATRIC DISORDERS, REGULATE THIS GABA-GLUTAMATE BALANCE. YOGA HAS BEEN STUDIED AS AN ADJUVANT TREATMENT ACROSS A BROAD RANGE OF PSYCHIATRIC DISORDERS AND IS SHOWN TO HAVE SHORT-TERM THERAPEUTIC GAINS. EMERGING EVIDENCE FROM RECENT CLINICAL IN VIVO EXPERIMENTS SUGGESTS THAT YOGA IMPROVES GABA-MEDIATED CORTICAL-INHIBITORY TONE AND ENHANCES PERIPHERAL OXYTOCIN LEVELS. THIS IS LIKELY TO HAVE A MORE CONTROLLED DOWNSTREAM RESPONSE OF THE HYPOTHALAMO-PITUITARY-ADRENAL SYSTEM BY MEANS OF REDUCED CORTISOL RELEASE AND HENCE A BLUNTED SYMPATHETIC RESPONSE TO STRESS. ANIMAL AND EARLY FETAL DEVELOPMENTAL STUDIES SUGGEST AN INTER-DEPENDENT ROLE OF OXYTOCIN AND GABA IN REGULATING SOCIAL BEHAVIORS. IN KEEPING WITH THESE OBSERVATIONS, WE PROPOSE AN INTEGRATED NEUROBIOLOGICAL MODEL TO STUDY THE MECHANISMS OF THERAPEUTIC BENEFITS WITH YOGA. APART FROM PROVIDING A NEUROSCIENTIFIC BASIS FOR APPLYING A TRADITIONAL SYSTEM OF PRACTICE IN THE CLINICAL SETTING, THIS MODEL CAN BE USED AS A FRAMEWORK FOR STUDYING YOGA MECHANISMS IN FUTURE CLINICAL TRIALS. 2019 15 1123 18 EFFICACY OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA. THE AIM OF THE STUDY WAS TO TEST THE EFFICACY OF A ONE MONTH IN-PATIENT NATUROPATHY AND YOGA PROGRAMME FOR PATIENTS WITH ASTHMA. RETROSPECTIVE DATA OF 159 BRONCHIAL ASTHMA PATIENTS, UNDERGOING THE NATUROPATHY AND YOGA PROGRAMME, WAS ANALYZED FOR FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME AT THE END OF 1 SECOND, MAXIMUM VOLUNTARY VENTILATION AND PEAK EXPIRATORY FLOW RATE ON ADMISSION, 11TH DAY, ON DISCHARGE AND ONCE IN THREE MONTHS FOR THREE YEARS. THE PAIRED SAMPLE T TEST RESULTS SHOWED SIGNIFICANT INCREASE IN THE FORCED VITAL CAPACITY AND FORCED EXPIRATORY VOLUME FROM THE DATE OF ADMISSION UP TO 6TH MONTH (P < 0.0035) POST BONFERRONI CORRECTION. MAXIMUM VOLUNTARY VENTILATION SIGNIFICANTLY INCREASED FROM ADMISSION TILL THE DATE OF DISCHARGE (P < 0.0035) AND PEAK EXPIRATORY FLOW RATE SIGNIFICANTLY INCREASED FROM ADMISSION TILL THE 36TH MONTH OF FOLLOW-UP (P < 0.0035), POST BONFERRONI CORRECTION. THIS VALIDATED THE BENEFICIAL EFFECT OF COMBINING NATUROPATHY AND YOGA FOR THE MANAGEMENT OF BRONCHIAL ASTHMA. 2014 16 1603 18 MENTAL DEPRESSION AND KUNDALINI YOGA. IN CASES OF MENTAL DEPRESSION, THE PLASMA SEROTONIN, MELATONIN AND GLUTAMATE LEVELS ARE INCREASED ALONG WITH THE LOWERING OF URINARY - 5 - HYDROXYINDOLE ACETIC ACID, PLASMA MONOAMINE OXIDASE AND CORTISOL LEVELS FOLLOWING THREE AND SIX MONTHS PRACTICE OF KUNDALINI YOGA. THE PULSE RATE AND BLOOD PRESSURE IN THESE PATIENTS ARE ALSO LOWERED AFTER KUNDALINI YOGA PRACTICE. THUS, THE PRACTICE OF KUNDALINI YOGA HELPS TO MAINTAIN A PERFECT HOMEOSTASIS BY BRINGING AN EQUILIBRIUM BETWEEN THE SYMPATHETIC AND PARASYMPATHETIC ACTIVITIES AND IT CAN BE USED AS A NON - MEDICAL MEASURE IN TREATING PATIENTS WITH MENTAL DEPRESSION. 1986 17 1453 20 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 18 751 12 EFFECT OF SHORT TERM YOGA PRACTICE ON VENTILATORY FUNCTION TESTS. TWENTYFIVE NORMAL MALE VOLUNTEERS UNDERGOING A TEN WEEKS COURSE IN THE PRACTICE OF YOGA HAVE BEEN STUDIED BY SOME PARAMETERS OF VENTILATORY FUNCTIONS TESTS. THE OBSERVATIONS RECORDED AT THE END OF TEN WEEKS OF THE COURSE HAVE SHOWN IMPROVED VENTILATORY FUNCTIONS IN THE FORM OF LOWERED RESPIRATORY RATE, INCREASED FORCED VITAL CAPACITY, FEV1, MAXIMUM BREATHING CAPACITY AND BREATH HOLDING TIME, WHILE TIDAL VOLUME AND %FEV1, DID NOT REVEAL ANY SIGNIFICANT CHANGE. THUS, A COMBINED PRACTICE OF YOGA SEEMS TO BE BENEFICIAL ON RESPIRATORY EFFICIENCY. 1988 19 2885 28 YOGA: AS AN ADJUNCT THERAPY TO TRIM DOWN THE AYURVEDIC DRUG REQUIREMENT IN NON INSULIN-DEPENDENT DIABETES MELLITUS. INTRODUCTION: IN SPITE OF A LARGE NUMBER OF DRUGS SHOWING ANTI-HYPERGLYCEMIC ACTIVITIES, NONE OF THEM HAVE BEEN SUCCESSFUL IN COMPLETE MANAGEMENT OF DIABETES MELLITUS (DM). YOGA AND AYURVEDA ARE THE TWO SCHOOLS OF THOUGHT IN INDIA, WHICH HAVE A HISTORY OF CURING DISEASES SINCE THOUSANDS OF YEARS. YOGIC TECHNIQUES AND AYURVEDIC HERBS HAVE PROVEN THEIR ANTI-DIABETIC POTENTIAL WITHOUT INDUCING UNTOWARD EFFECTS. THE PRESENT STUDY COMBINES AYURVEDIC MEDICATION WITH YOGA TECHNIQUES AS A NEW APPROACH TOWARD HEALING DM. AIMS AND OBJECTIVES: TO ASSESS THE EFFECT OF YOGA THERAPY IN THE MANAGEMENT OF NON INSULIN-DEPENDENT DM (NIDDM) AND TO DECREASE THE ORAL DRUG DOSE REQUIREMENT OF GUDUCI GHANA TABLET. MATERIALS AND METHODS: THIRTY KNOWN NIDDM PATIENTS OF BOTH GENDERS, WHO WERE ON GUDUCI GHANA (SOLIDIFIED AQUEOUS EXTRACT OF TINOSPORA CORDIFOLIA (WILLD.) MIERS.) TABLETS FROM PAST 2 MONTHS AS AYURVEDIC REMEDY FOR DM WERE SELECTED. ALONG WITH GUDUCI GHANA ADMINISTRATION, THE SUBJECTS WERE INSTRUCTED TO FOLLOW YOGIC PROCEDURES INCLUDING ASANAS, PRANAYAMA, AND SUDDHI KRIYAS. THE STUDY WAS CONDUCTED FOR 8 WEEKS, WHEREIN FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS ALONG WITH RELIEF IN SIGN AND SYMPTOMS WERE ASSESSED AT EVERY 2 WEEKS INTERVALS, AND ACCORDING TO RELIEF IN SIGN AND SYMPTOMS, TAPERING OF DRUG DOSAGE WAS CARRIED OUT. THE OBTAINED DATA WERE ANALYZED STATISTICALLY BY APPLYING PAIRED T-TEST. RESULTS AND CONCLUSION: THE RESULTS OBTAINED WERE PROMISING AS THE RELIEF IN DIABETIC SYMPTOMATOLOGY WAS HIGHLY SIGNIFICANT IN TERMS OF P VALUE. 80.83% REDUCTION IN DOSE OF GUDUCI GHANA TABLETS AND 7.85% AND 8.78% FALL IN FBS AND PPBS LEVELS, RESPECTIVELY, AFTER THE COMPLETE COURSE OF TREATMENT. THE OBTAINED P VALUE SHOWED HIGHLY SIGNIFICANT RESULTS. 2014 20 749 18 EFFECT OF SAHAJA YOGA PRACTICE ON SEIZURE CONTROL & EEG CHANGES IN PATIENTS OF EPILEPSY. THE EFFECT OF SAHAJA YOGA MEDITATION ON SEIZURE CONTROL AND ELECTROENCEPHALOGRAPHIC ALTERATIONS WAS ASSESSED IN 32 PATIENTS OF IDIOPATHIC EPILEPSY. THE SUBJECTS WERE RANDOMLY DIVIDED INTO 3 GROUPS. GROUP I (N = 10) PRACTISED SAHAJA YOGA FOR 6 MONTHS, GROUP II (N = 10) PRACTISED EXERCISES MIMICKING SAHAJA YOGA FOR 6 MONTHS AND GROUP III (N = 12) SERVED AS THE EPILEPTIC CONTROL GROUP. GROUP I SUBJECTS REPORTED A 62 PER CENT DECREASE IN SEIZURE FREQUENCY AT 3 MONTHS AND A FURTHER DECREASE OF 86 PER CENT AT 6 MONTHS OF INTERVENTION. POWER SPECTRAL ANALYSIS OF EEG SHOWED A SHIFT IN FREQUENCY FROM 0-8 HZ TOWARDS 8-20 HZ. THE RATIOS OF EEG POWERS IN DELTA (D), THETA (T), ALPHA (A) AND BETA (B) BANDS I.E., A/D, A/D + T, A/T AND A + B/D + T WERE INCREASED. PER CENT D POWER DECREASED AND PER CENT A INCREASED. NO SIGNIFICANT CHANGES IN ANY OF THE PARAMETERS WERE FOUND IN GROUPS II AND III, INDICATING THAT SAHAJA YOGA PRACTICE BRINGS ABOUT SEIZURE REDUCTION AND EEG CHANGES. SAHAJA YOGA COULD PROVE TO BE BENEFICIAL IN THE MANAGEMENT OF PATIENTS OF EPILEPSY. 1996